Anthracyclines as tumor cell differentiating agents: effects on the regulation of erythroid gene expression.

Jeannesson, P; Lahlil, R; Chenais, B; Devy, L; Gillet, R; Aries, A; Morceau, F; Trentesaux, C

Jeannesson, P; Lahlil, R; Chenais, B; Devy, L; Gillet, R; Aries, A; Morceau, F; Trentesaux, C.

Affiliation

Jeannesson P; Laboratoire de Biochimie, GIBSA, Faculté de Pharmacie, Reims, France.

Leuk Lymphoma ; 26(5-6): 575-87, 1997 Aug.

Article in En | MEDLINE | ID: mdl-9389364

Subject(s)

Aclarubicin/analogs & derivatives; Antibiotics, Antineoplastic/pharmacology; Doxorubicin/pharmacology; Erythroid Precursor Cells/drug effects; Erythroid Precursor Cells/physiology; Gene Expression Regulation, Leukemic/drug effects; Aclarubicin/pharmacology; Carbohydrate Sequence; Cell Differentiation/drug effects; Cell Differentiation/physiology; Humans; Leukemia, Erythroblastic, Acute/drug therapy; Leukemia, Erythroblastic, Acute/metabolism; Leukemia, Erythroblastic, Acute/pathology; Leukemia, Myeloid/drug therapy; Leukemia, Myeloid/metabolism; Leukemia, Myeloid/pathology; Molecular Sequence Data

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Aclarubicin / Doxorubicin / Erythroid Precursor Cells / Gene Expression Regulation, Leukemic / Antibiotics, Antineoplastic Limits: Humans Language: En Journal: Leuk Lymphoma Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 1997 Document type: Article Affiliation country: France Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links